Truist raises Protagonist Therapeutics stock price target on Icotyde outlook

Truist raises Protagonist Therapeutics stock price target on Icotyde outlook

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.